Condition
Embolic Stroke of Undetermined Source clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Embolic Stroke of Undetermined Source clinical trials that are recruiting, at sites in 7 countries (most in South Korea (3), Switzerland (1), Germany (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 7Countries
Newest Embolic Stroke of Undetermined Source clinical trials
All recruiting trials (9)
-
PFO closure versus blood thinners to prevent repeat stroke in older adults
This study will test whether closing a patent foramen ovale or taking direct oral anticoagulants better prevents repeat strokes in adults over 60 with PFO-related embolic stroke.
-
AI analysis of ECGs to predict atrial fibrillation risk in ESUS patients with an implantable cardiac monitor.
This project tests whether an AI tool called SmartECG-AF can use a routine 12-lead ECG to predict which ESUS patients with an implantable cardiac monitor will develop atrial fibrillation.
-
Using a MEMO wearable patch to find atrial fibrillation after an unexplained stroke
This trial will try a wearable single-lead ECG patch (MEMO Patch) to find previously missed atrial fibrillation in adults who had an embolic stroke of unknown cause.
-
Left atrial function in people with unexplained (cryptogenic) stroke.
This will see if lower left atrial strain on a heart ultrasound is linked to unexplained (cryptogenic) stroke and to higher risk of another stroke in adults who had a stroke without a known cause.
-
High-coverage carotid stent versus medical treatment to prevent embolism from symptomatic non-stenotic carotid disease (SyNC)
This trial will test whether placing a high‑coverage carotid stent, compared with medical therapy alone, reduces repeat embolic events in people who recently had symptoms from low‑grade (10–49%) carotid plaques with high‑risk features.
-
Investigating the effects of Empagliflozin on heart function after unexplained strokes
This study is testing if the medication Empagliflozin can help improve heart function and prevent future strokes in people who have had unexplained strokes.
-
Identifying New Cancer After Ischemic Stroke in High-Risk Patients
This study is trying to see if people who had an ischemic stroke and have high D-dimer levels are more likely to be diagnosed with hidden cancer within a year.
-
Registry of elderly patients with embolic stroke of undetermined source and patent foramen ovale
This study is testing if closing a small hole in the heart can help older patients who have had a certain type of stroke feel better compared to just taking standard medication.
-
Identifying echocardiographic predictors of atrial fibrillation
This study is testing if certain heart ultrasound measurements can help find atrial fibrillation in patients who have had a stroke or a mini-stroke.
Related topics
Quick answers
How many Embolic Stroke of Undetermined Source clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in South Korea (3 trials), Switzerland (1 trial), Germany (1 trial), United Kingdom (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.